The Shareholders Foundation announces that an investigation on behalf of investors in shares of AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) was launched over potential breaches of fiduciary duties that caused damages to the company and NASDAQ:AVEO stockholders. AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) shares after opening at $1.26 moved to $1.29 on last trade day and at the end of the day closed at $1.26. Company price to sales ratio in past twelve months was calculated as 50.18 and price to cash ratio as 0.55. AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) showed a negative weekly performance of -10.64%.
Baxano Surgical, Inc. (Nasdaq:BAXS) announced that it plans to release first quarter 2014 financial and operating results after market close on Thursday, May 8, 2014. Ken Reali, President and Chief Executive Officer and Tim Shannon, Chief Financial Officer, will host a conference call starting at 4:30 pm ET on the same day. Baxano Surgical Inc (NASDAQ:BAXS) shares fell -4.40% in last trading session and ended the day on $0.870. BAXS return on equity ratio is recorded as -102.20% and its return on assets is -69.20%. Baxano Surgical Inc (NASDAQ:BAXS) yearly performance is -59.15%.
IPC The Hospitalist Company (NASDAQ:IPCM) was upgraded by stock analysts at Wells Fargo & Co. from a “market perform” rating to an “outperform” rating in a report issued on Friday. IPC The Hospitalist Company Inc (NASDAQ:IPCM) shares moved down -1.55% in last trading session and was closed at $40.67, while trading in range of $40.41-$41.43. IPC The Hospitalist Company Inc (NASDAQ:IPCM) year to date performance is -31.52%.
Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) announced that the Company will present at the 39(th) Annual Deutsche Bank Health Care Conference on May 7 — 8, 2014 at the InterContinental Hotel in Boston, MA. Eagle Pharmaceuticals Inc (NASDAQ:EGRX) weekly performance is -18.08%. On last trading day company shares ended up $9.88. Eagle Pharmaceuticals Inc (NASDAQ:EGRX) distance from 50-day simple moving average is -24.14%. Analysts mean target price for the company is $21.67.